Given these findings of reduced T cell infiltration and function in IFNγR1KO melanoma, it would be interesting to delineate the specific molecular and biochemical mechanisms underlying the immunomodulation of TILs by tumor IFN-γ signaling in the future. The gene discussed is IFNG; the disease is neoplasm.